Sulfisoxazole
From Wikipedia, the free encyclopedia
Sulfisoxazole
|
|
Systematic (IUPAC) name | |
4-amino-N-(3,4-dimethyloxazol-5-yl)- benzenesulfonamide | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C11H13N3O3S |
Mol. mass | 267.305 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | excreted, unchanged, in urine |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
avoid w/in two months of term |
Legal status | |
Routes | ? |
Sulfisoxazole is a sulfa drug based upon sulfonamide with a substituted oxazole. It has antibiotic activity against a wide range of gram- negative and gram-positive organisms. It is sometimes given in combination with erythromycin or phenazopyridine. It is used locally in a 4% solution or ointment.
[edit] External links
- MeSH Sulfisoxazole
- MedlinePlus DrugInfo medmaster-a601049
- MedlinePlus DrugInfo medmaster-a601115
- DDB 30455